Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by BearDownAZon Apr 22, 2016 11:18am
97 Views
Post# 24798965

RE:RE:RE:RE:SIX POINT DROP/ PRESENTATION YESTERDAY????

RE:RE:RE:RE:SIX POINT DROP/ PRESENTATION YESTERDAY????

JK,

I asked Sarah this morning:

"It would seem that the only way that shareholders can view that Zenith and Resverlogix presentations is by registering for the conference or webinar. Is this correct? Does Resverlogix and/or Zenith plan to make their NYAS presentations available on their websites at a later date? If not, will Resverlogix and/or Zenith make a similar webcast presentation to shareholders soon thereafter?"

Sarah responded:
"If you visit the NYAS website you can review previous events E-briefings and webinars. I personally am assisting in organizing the E-briefing/webinar for this event. Our event will look similar to those on their website. So the answer is yes you will be able to view full presentations via the e-briefing for both RVX and ZEN. Once the page is active, I will further push this info out via our blog and Twitter."
-------------------------------------------------
So the revised explanation is that if you want to view the presentations live (in person or remote via webinar), then you must pay and register. However, there seems to be plans in place per Sarah to make the E-briefing/webinar will be archived on the NYAS website for later viewing.
Best regards,
BearDownAZ

P.S. Originally posted here on Agoracom.

Bullboard Posts